Sullivan, Bruyette, Speros & Blaney’s Texas Instruments TXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$418K Sell
2,213
-492
-18% -$85.5K 0.02% 201
2020
Q4
$444K Buy
2,705
+150
+6% +$23.3K 0.02% 180
2020
Q3
$365K Buy
2,555
+140
+6% +$19K 0.02% 180
2020
Q2
$307K Hold
2,415
0.02% 181
2020
Q1
$241K Sell
2,415
-32
-1% -$3.84K 0.02% 188
2019
Q4
$314K Sell
2,447
-240
-9% -$29.6K 0.02% 191
2019
Q3
$347K Buy
2,687
+199
+8% +$24.5K 0.02% 168
2019
Q2
$286K Buy
2,488
+221
+10% +$24.7K 0.02% 186
2019
Q1
$240K Buy
+2,267
New +$235K 0.01% 188
2017
Q4
Sell
-2,948
Closed -$264K 170
2017
Q3
$264K Buy
+2,948
New +$242K 0.03% 137
2016
Q4
Sell
-4,043
Closed -$284K 147
2016
Q3
$284K Buy
4,043
+19
+0.5% +$1.29K 0.03% 115
2016
Q2
$252K Buy
+4,024
New +$239K 0.03% 114

Other funds holding TXN

Sullivan, Bruyette, Speros & Blaney's TXN Position: Q1 2021 in Review

Sullivan, Bruyette, Speros & Blaney reduced its Texas Instruments (TXN) stake by 18% in Q1 2021, selling an estimated $85.5K and leaving 2,213 shares worth $418K. The position accounts for 0.02% of the portfolio, ranked #201.

Sullivan, Bruyette, Speros & Blaney first reported a position in TXN in Q2 2016 and has held it in 12 quarters since. The position peaked at $444K in Q4 2020. 1,883 funds tracked by Wall St. Rank hold TXN as of Q1 2021.

  • Sullivan, Bruyette, Speros & Blaney held 2,213 shares of Texas Instruments worth $418K as of Q1 2021.
  • Sullivan, Bruyette, Speros & Blaney sold 492 Texas Instruments shares in Q1 2021, an estimated $85.5K.
  • Texas Instruments made up 0.02% of Sullivan, Bruyette, Speros & Blaney's portfolio in Q1 2021, its #201 holding.
  • Sullivan, Bruyette, Speros & Blaney first reported a position in Texas Instruments in Q2 2016 and has held it in 12 quarters since.
  • Sullivan, Bruyette, Speros & Blaney's Texas Instruments position peaked at $444K in Q4 2020.
  • 1,883 funds tracked by Wall St. Rank held Texas Instruments as of Q1 2021.

Based on Sullivan, Bruyette, Speros & Blaney's 13F filing for Q1 2021, filed 10 May 2021.